Relmada Therapeutics, Inc. (RLMD) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Oramed Pharmaceuticals, Inc.

Abeona Therapeutics, Inc.

Eton Pharmaceuticals, Inc.

MediWound Ltd.

Milestone Pharmaceuticals, Inc.

Esperion Therapeutics, Inc.

ProQR Therapeutics NV

Ocugen, Inc.

DiaMedica Therapeutics, Inc.

Relmada Therapeutics, Inc.

MediciNova, Inc.

Why is Relmada Therapeutics, Inc. ?

Unrated Stock - No Analysis Available

Real-Time Research Report

Verdict Report

No Data Found

Is Relmada Therapeutics, Inc. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Relmada Therapeutics, Inc.

1950.68%

0.58

163.49%

S&P 500

14.9%

0.77

19.29%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

EBIT Growth (5y)

-7.23%

EBIT to Interest (avg)

-97.65

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-1.21

Sales to Capital Employed (avg)

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

46.41%

ROCE (avg)

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

47.88

EV to EBIT

-7.59

EV to EBITDA

-7.60

EV to Capital Employed

-99.37

EV to Sales

PEG Ratio

Dividend Yield

ROCE (Latest)

Negative Capital Employed

ROE (Latest)

-592.78%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bullish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Bullish

Moving Averages

Bullish (Daily)

KST

Mildly Bearish

Bullish

Dow Theory

No Trend

Mildly Bullish

OBV

No Trend

Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

12What is working for the Company

OPERATING CASH FLOW(Y)

Highest at USD -39.99 MM

RAW MATERIAL COST(Y)

Fallen by 0% (YoY

DEBT-EQUITY RATIO (HY)

Lowest at -146.71 %

PRE-TAX PROFIT(Q)

At USD -10.16 MM has Grown at 53.82%

NET PROFIT(Q)

At USD -10.16 MM has Grown at 53.82%

-3What is not working for the Company

ROCE(HY)

Lowest at -196.79%

CASH AND EQV(HY)

Lowest at USD 34.51 MM

Here's what is working for Relmada Therapeutics, Inc.

Operating Cash Flow

Highest at USD -39.99 MM and Grown

In each year in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (USD MM)

Pre-Tax Profit

At USD -10.16 MM has Grown at 53.82%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (USD MM)

Net Profit

At USD -10.16 MM has Grown at 53.82%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is positive

Net Profit (USD MM)

Debt-Equity Ratio

Lowest at -146.71 %

in the last five Semi-Annual periods

MOJO Watch

The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Raw Material Cost

Fallen by 0% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Relmada Therapeutics, Inc.

Cash and Eqv

Lowest at USD 34.51 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is deteriorating

Cash and Cash Equivalents